Home
>
Stock Market
>
>
Glaxosmithkline Pharmaceuticals Ltd

Glaxosmithkline Pharmaceuticals Ltd share price and stock overview

Glaxosmithkline Pharmaceuticals Ltd (NSE: GLAXO, BSE: 500660) operates in the Pharmaceuticals - Multinational sector. The stock has an ISIN of INE159A01016 and a face value of Rs 10. As of 25 October 2026, it trades at Rs (2,404.70) with a market capitalisation of Rs 40738.76 crore. Figures are live and subject to change.

Glaxosmithkline Pharmaceuticals Ltd

Pharmaceuticals - Multinational

NSE BSE

2,404.70 -29.00 (-1.19%) downArrowC

As on: 25-Oct-2026 , 02:15 AM

Market Cap(₹Cr) 40738.76

Book Value(₹Cr) 132.2958859

BSE Code : 500660 NSE Symbol : GLAXO EPS(TTM) : 62.48 ISIN Demat : INE159A01016 P/E(TTM) : 38.49 Face Value(₹) : 10 Div & Yield % : 2.37

Today Market

Stock Performance

Today Market

Today's High

73,766.51

Todday's Low

72,452.37

Open at

73,665.64

Previous Close

73,249.39

Volumes

Avg Price

-125.56

Historical Performance

News

13 Oct 26

GlaxoSmithKline Pharmaceuticals to review financial results at board meeting November 3, 2026

GlaxoSmithKline Pharmaceuticals Limited will hold a board meeting on Tuesday, November 3, 2026, to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2026, the company said in a filing to the BSE Limited and the National Stock Exchange of India Limited.

12 Oct 26

GlaxoSmithKline Pharmaceuticals Limited reports certificate compliance with SEBI regulations

GlaxoSmithKline Pharmaceuticals Limited informed the BSE Limited and the National Stock Exchange of India Limited that it has received a certificate from Kfin Technologies Limited, its Registrar and share Transfer Agent, for the quarter ended September 30, 2026, in compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

25 Sep 26

GlaxoSmithKline Pharmaceuticals Limited will halt share trading following Q2 2026 results

GlaxoSmithKline Pharmaceuticals Limited will close its trading window for share purchases and sales from October 1, 2026, until 48 hours after the announcement of its unaudited financial results for the second quarter and half year ended September 30, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015.

03 Aug 26

GSK India’s revenue rose 15% to INR 924 crores in Q1 2026, PAT up 24%

GlaxoSmithKline Pharmaceuticals Ltd (GSK India) announced a 15% year-over-year increase in revenue to INR 924 crores for the first quarter ended June 30, 2026, with Profit After Tax (PAT) rising 24% to INR 253 crores, according to a press release issued Tuesday.

Historical Prices

Share Price Chart

Historical Share Price

Date	Open Price (₹)	High Price(₹)	Low Price(₹)	Close Price(₹)	Total Volume	No of Trades	Net Turnover(₹)	NIFTY
23-10-26	2432.80	2432.80	2344.10	2404.70	56174	13901	134294244.20	22600.00
22-10-26	2460.00	2464.60	2422.20	2433.70	22943	7191	55907855.40	22687.65
21-10-26	2460.00	2517.90	2445.00	2464.40	27689	7310	68391813.10	22811.35
19-10-26	2555.10	2555.20	2473.30	2495.40	21147	6158	52924977.60	22888.95
16-10-26	2530.00	2573.20	2518.40	2566.10	61686	14788	157715338.80	23146.15
15-10-26	2538.00	2538.00	2491.20	2524.70	45439	10765	114322050.90	22997.35
14-10-26	2536.30	2548.30	2502.00	2538.90	41627	8767	105227419.00	22622.70
13-10-26	2525.10	2545.00	2495.00	2536.30	31087	8630	78406029.10	22721.95
12-10-26	2530.10	2555.80	2520.10	2531.50	28359	7234	71987875.20	22363.35
09-10-26	2534.40	2565.00	2485.00	2540.30	41351	9943	104804486.80	22520.45

12 3 ...

Fundamentals

Company Valuation

Market Cap (₹cr)

40738.76

PE Ratio

38.49

PB Ratio

18.18

Dividend Yield

2.37

ROE

48.29

ROCE

58.17

Book Value (₹)

132.2958859

Face Value (₹)

Share Holding Pattern

Category of Shareholder	No of Shares	% Share Holdings	Demat Shares	Share Holders

Promoter & Group

Foreign

Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	0	0.00	0	0
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0

Sub Total

127054524

75.00

127054524

Indian

Bodies Corporate-Indian (Promoter & Group)	0	0.00	0	0
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	0	0.00	0	0
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	0	0.00	0	0
Others	0	0.00	0	0

Sub Total

0.00

Total ShareHolding for Promoter & Group

127054524

75.00

127054524

Publice Share Holding

Institution

Government(Central / State)	94	0.00	94	2
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	18048	0.01	11084	18
Foreign Bank	111	0.00	111	1
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	8044401	4.75	8044401	241
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	3935853	2.32	3935853	16
Mutual Funds / UTI	10286404	6.07	10279964	36
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	125660	0.07	112776	17
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0

Sub total

22410571

13.23

22384283

331

Non Institution

Bodies Corporate	1194089	0.70	1182089	818
Clearing Members	353	0.00	353	3
Directors & their Relatives	600	0.00	600	1
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	883130	0.52	876764	4130
Foreign Non Institution Other	0	0.00	0	0
Hindu Undivided Families	365258	0.22	365258	2217
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	331615	0.20	331615	11
Individuals holding nominal share capital up to Rs. 1 lakh	16021056	9.46	15005060	111795
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	31398	0.02	31398	26
Others	1113440	0.66	1113440	1

Sub Total

19940939

11.77

18906577

119002

Total Public Shareholding

42351510

25.00

41290860

119333

Total of Promoter & Public ShareHolding

169406034

100.00

168345384

119337

Shares held by Custodians and against which Depository Receipts have been issued

ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0

Total Shares held by Custodians and against which Depository Receipts have been issued

0.00

Grand Total

169406034

100.00

168345384

119337

Financials (₹ in cr)

Consolidated Standalone

Year End	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Net Sales	3,821.67	3,749.21	3,453.71	3,251.72	3,278.03
OPM (%)	36.25	33.48	27.79	25.75	23.41
OP	1,385.39	1,255.19	959.80	837.37	767.47
Other Income	145.36	145.93	122.59	100.66	75.78
PBIDT	1,475.19	1,327.98	887.67	903.98	849.23
INTEREST	2.73	1.31	1.80	1.81	2.00
PBDT	1,472.46	1,326.67	885.87	902.17	847.23
PBT	1,426.64	1,264.57	672.57	835.43	790.62
EO	20.63	4.69	-143.62	-0.97	11.58
PBT after EO	1,406.01	1,259.88	816.19	836.40	779.05
TAXES	370.03	332.30	226.23	228.76	398.28
PAT	1,035.98	927.58	589.96	610.69	1,694.72
EPS	61.15	54.76	34.83	36.05	100.04
Raw Material	11.41	13.33	15.79	13.15	18.64
Power and Fuel	0.79	0.80	0.86	0.91	0.85
Employee Cost	15.89	15.46	18.08	18.30	18.62
Other Manufacturing Expenses	1.85	2.19	2.47	2.27	2.85
Selling and Administration Expenses	9.59	10.24	10.85	11.39	10.48
Miscellaneous Expenses	1.46	1.94	1.97	2.11	1.77
Revenue (Growth %)	1.93	8.56	6.21	-0.80	12.05
PBIDT (Growth %)	11.08	49.60	-1.80	6.45	58.40
PAT (Growth %)	11.69	57.23	-3.39	-63.97	373.19
PBIDT (Margin %)	38.60	35.42	25.70	27.80	25.91
PAT (Margin %)	27.11	24.74	17.08	18.78	51.70

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Share Capital	169.41	169.41	169.41	169.41	169.41	169.41
Reserves Total	2071.77	1779.82	1614.69	1583.59	2508.21	1327.71
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	2241.18	1949.23	1784.10	1753.00	2677.62	1497.12
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	33.27	9.95	18.67	15.54	20.08	34.63
Total Debt	33.27	9.95	18.67	15.54	20.08	34.63
Other Liabilities	259.36	248.40	246.30	254.22	263.00	260.29
Total Liabilities	2533.81	2207.58	2049.07	2022.76	2960.70	1792.04
APPLICATION OF FUNDS :
Gross Block	700.21	668.95	683.12	635.93	593.89	602.89
Less : Accumulated Depreciation	419.48	385.31	361.86	305.99	263.26	216.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	280.73	283.64	321.26	329.94	330.63	386.89
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	32.93	14.32	13.93	20.31	30.50	13.21
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	1416.32	1142.74	837.72	542.78	390.09	24.49
Current Assets, Loans & Advances
Inventories	430.35	463.17	514.30	437.70	512.71	523.34
Sundry Debtors	273.11	292.55	222.06	192.38	205.24	215.60
Cash and Bank Balance	1354.79	1400.89	1061.20	1150.73	2479.11	1157.68
Loans and Advances	93.90	108.70	155.08	167.62	108.05	274.71
Total Current Assets	2152.16	2265.30	1952.62	1948.43	3305.12	2171.33
Less : Current Liabilities and Provisions
Current Liabilities	777.26	952.43	806.64	590.94	1046.53	866.70
Provisions	963.85	940.93	692.10	713.99	615.36	438.35
Total Current Liabilities & Provisions	1741.11	1893.36	1498.74	1304.94	1661.90	1305.05
Net Current Assets	411.05	371.95	453.88	643.49	1643.22	866.28
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	145.53	155.99	163.08	151.38	131.67	117.24
Deferred Tax Liability	11.91	15.35	17.14	18.20	18.89	15.57
Net Deferred Tax	133.62	140.64	145.94	133.18	112.78	101.67
Other Assets	259.16	254.30	276.33	353.06	453.48	399.49
Total Assets	2533.81	2207.58	2049.05	2022.76	2960.70	1792.03
Contingent Liabilities	512.59	453.28	384.15	350.59	351.10	485.78

Cash Flow (₹ in cr)

Yearly Cash Flow	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Financing Activities	-524.24	-1,544.18	-561.50	-769.42	-737.07
Investing Activities	-419.66	805.19	14.97	-36.53	385.25
Net Cash Flow	-124.11	-251.05	32.41	474.07	529.60
Operating Activities	819.79	487.94	578.94	1,280.03	881.42

Peers

Balance Sheet Financial Ratios Profit & Loss

Abbott India Ltd

25,030.00

(-1.30%)

Astrazeneca Phar...

5,988.50

(-1.84%)

Novartis India L...

1,824.50

(+8.31%)

Pfizer Ltd

3,612.30

(-2.08%)

Procter & Gamble...

5,015.00

(-0.94%)

Sanofi Consumer ...

3,207.90

(-1.68%)

Sanofi India Ltd

2,772.80

(-2.06%)

Corporate Actions

Bonus Dividends Splits

Date	Corporate Action	Information
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer

RSK

Renu S. Karnad

Chairman & Non Executive Dir.

Executive

Functional Directors

Bhushan Akshikar

Managing Director

Ronojit Biswas

Whole Time Director & CFO

Dir.

KJF

Karine J F Natland

Non Executive Director

Exec.

Independent Directors

Manu Anand

Independent Non Exe. Director

Ind.

Sunita Maheshwari

Independent Non Exe. Director

Ind.

Somasundaram Palamadairamaswamy

Independent Non Exe. Director

Ind.

Anup Wadhawan

Independent Non Exe. Director

Ind.

Company Secretary & Compliance

AAN

A A Nadkarni

VP / Company Secretary / Compliance Officer

Sec.

Frequently Asked Questions

What is the NSE symbol and BSE code for Glaxosmithkline Pharmaceuticals Ltd? −

Glaxosmithkline Pharmaceuticals Ltd trades on NSE under GLAXO and on BSE under code 500660. The ISIN is INE159A01016 and the face value is Rs 10.

What is the share price of Glaxosmithkline Pharmaceuticals Ltd today? +

As of 25 October 2026, Glaxosmithkline Pharmaceuticals Ltd trades at Rs 2,404.70, a change of -29.00 (-1.19%) on the day. Prices are live and subject to change.

What is the market capitalisation of Glaxosmithkline Pharmaceuticals Ltd? +

As of 25 October 2026, Glaxosmithkline Pharmaceuticals Ltd has a market cap of about Rs 40738.76 crore. This figure is live and moves with the share price.

Is Glaxosmithkline Pharmaceuticals Ltd profitable? +

In March 2026, Glaxosmithkline Pharmaceuticals Ltd reported a profit after tax of Rs 1,035.98 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Glaxosmithkline Pharmaceuticals Ltd? +

: As of 25 October 2026, the PE (TTM) for Glaxosmithkline Pharmaceuticals Ltd is 38.49 and the price-to-book ratio is 18.18. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Glaxosmithkline Pharmaceuticals Ltd pay a dividend? +

As of 25 October 2026, the dividend yield for Glaxosmithkline Pharmaceuticals Ltd is 2.37%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd? +

As of the latest disclosed pattern, promoters hold 75.00% of Glaxosmithkline Pharmaceuticals Ltd. Public shareholding is 25.00%, including mutual funds at 6.07% and foreign institutional investors at 4.75%.

What were the latest annual financials of Glaxosmithkline Pharmaceuticals Ltd? +

In March 2026, Glaxosmithkline Pharmaceuticals Ltd reported net sales of Rs 3,821.67 crore, revenue growth of 1.93%, and earnings per share of Rs 61.15.